Latest Rasburicase Stories
As an alternative to a conventional treatment for gout that some patients may not respond to, patients with severe, chronic gout who received the medication pegloticase for 6 months had greater improvement in measures of uric acid levels as well as physical function and quality of life.
SILVER SPRING, Md., Sept. 14 /PRNewswire-USNewswire/ -- The U.S.
BRIDGEWATER, N.J., Oct. 16 /PRNewswire-FirstCall/ -- Sanofi-aventis U.S. announced that the U.S.
The U.S. Food and Drug Administration has approved a new drug for gout, the first new prescription for the painful condition in 40 years, its maker says. Takeda Pharmaceuticals North America Inc.
- Results Presented at ASH Annual Meeting - SAN FRANCISCO, Dec. 6 /PRNewswire-FirstCall/ -- Sanofi-aventis today announced results of a randomized phase III study presented at the 50th Annual Meeting of the American Society of Hematology.
- A trick or prank.